about
Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.Using germline genotype in cancer pharmacogenetic studies.Decision criteria for rational selection of homogeneous genotyping platforms for pharmacogenomics testing in clinical diagnostics.Molecular heterogeneity of glioblastoma and its clinical relevance.Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.Safe and effective medicines for all: is personalized medicine the answer?Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
P2860
Q35085742-79FA3604-2389-44D1-BD81-BB3B6B362BBFQ37570332-E2550D2C-D5F2-4C2B-B9ED-0BC6F2FEA65CQ37700743-0DEF898C-4EF6-4F27-A8A0-6D280561251BQ38243193-F5BCF90A-5231-4BA7-89CA-2A22D8C2A3A8Q43053804-03E1B3BC-B869-467D-8240-3B269FD60502Q44483899-F78487B2-AAFF-44E0-9438-D1F1C170F7D5Q47742671-C626DFF0-0B84-4355-B744-681F00A7B709
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Somatic pharmacogenomics in cancer.
@en
Somatic pharmacogenomics in cancer.
@nl
type
label
Somatic pharmacogenomics in cancer.
@en
Somatic pharmacogenomics in cancer.
@nl
prefLabel
Somatic pharmacogenomics in cancer.
@en
Somatic pharmacogenomics in cancer.
@nl
P2860
P356
P1476
Somatic pharmacogenomics in cancer.
@en
P2093
O N Ikediobi
P2860
P2888
P304
P356
10.1038/TPJ.2008.8
P577
2008-08-05T00:00:00Z